21.03.2005 18:07:00

Dade Behring Sponsors C-Reactive Protein Website for Healthcare Provid

Dade Behring Sponsors C-Reactive Protein Website for Healthcare Providers and Patients


    Business Editors/Health/Medical Writers

    DEERFIELD, Ill.--(BUSINESS WIRE)--March 21, 2005--As a part of Dade Behring's (NASDAQ: DADE) ongoing commitment to cardiac diagnostics, we are pleased to announce that the company is now a sponsor of a cutting-edge website for education and reference on C-Reactive Protein (CRP) and a variety of healthcare issues for medical professionals and the patients they serve. The website, CRPhealth.com, was launched in November 2004 by E-MedHosting.com Inc., and serves as a one-stop reference site for the latest updates in CRP, and the role of inflammation in heart disease and stroke.
    CRPhealth.com is updated daily and includes content on the use of hsCRP as a prognostic indicator of cardiovascular disease and stroke, and the results of observational studies and clinical trials. The editorial board of specialists reviewing all content includes Dr. Paul Ridker (Eugene Braunwald Professor of Medicine, Harvard Medical School), Dr. Nader Rifai (Associate Professor, Harvard Medical School), and Dr.Wolfgang Koenig (Professor of Medicine/Cardiology, University of Ulm Medical Center).
    The website's content for both healthcare providers and the general public features: interactive forums, multimedia presentations by experts on inflammation and heart disease, case studies, discussion forums, self-assessments, slide and video libraries, treatment guidelines, references, polls, the latest medical publications on CRP, and Frequently Asked Questions.
    "This new website exemplifies our company's continuous efforts to make information available to healthcare providers and patients that meets their needs and enables the best quality of care," said Jim Reid-Anderson, Chairman, President and CEO, Dade Behring. "Dade Behring is committed to providing state-of-the-art cardiac testing for the clinical laboratory, and sponsoring the only website to date exclusively dedicated to the dissemination of CRP-related information is a natural fit for our company."
    With 2004 revenues of nearly $1.6 billion, Dade Behring is the world's largest company dedicated solely to clinical diagnostics. It offers a wide range of products, systems and services designed to meet the day-to-day needs of labs, delivering innovative solutions to customers and enhancing the quality of life for patients. Additional company information is available on the internet at www.dadebehring.com.

--30--AC/cg*

CONTACT: Dade Behring Deirdra Dougherty, 302-631-6872

KEYWORD: ILLINOIS INDUSTRY KEYWORD: MEDICAL EDUCATION BANKING MEDICAL DEVICES TELECOMMUNICATIONS PRODUCT INTERNET SOURCE: Dade Behring

Copyright Business Wire 2005

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Dade Behring Holdings Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Dade Behring Holdings Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 20 080,80 0,20%